Total Payments
$8,902
2024 Payments
$1,887
Companies
47
Transactions
493
Medicare Patients
4,889
Medicare Billing
$262,597
Payment Breakdown by Category
Food & Beverage$8,902 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,902 | 493 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,617 | 102 | $0 (2024) |
| Abbott Laboratories | $1,371 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $647.48 | 45 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $620.86 | 47 | $0 (2023) |
| Amgen Inc. | $421.90 | 27 | $0 (2024) |
| iRhythm Technologies, Inc. | $394.63 | 3 | $0 (2024) |
| Endologix, Inc. | $372.48 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $311.49 | 24 | $0 (2024) |
| PFIZER INC. | $310.78 | 23 | $0 (2024) |
| ABIOMED | $308.43 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,887 | 85 | Abbott Laboratories ($628.35) |
| 2023 | $1,160 | 55 | Abbott Laboratories ($308.38) |
| 2022 | $1,308 | 64 | Novartis Pharmaceuticals Corporation ($428.78) |
| 2021 | $831.01 | 54 | NOVARTIS PHARMACEUTICALS CORPORATION ($461.28) |
| 2020 | $667.04 | 38 | Abbott Laboratories ($253.79) |
| 2019 | $574.70 | 41 | Boehringer Ingelheim Pharmaceuticals, Inc. ($80.51) |
| 2018 | $955.56 | 47 | Endologix, Inc. ($352.93) |
| 2017 | $1,519 | 109 | AstraZeneca Pharmaceuticals LP ($229.47) |
All Payment Transactions
493 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $43.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Abbott Laboratories | ULTREON (Device) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Vascular | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.69 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Vascular | ||||||
| 11/12/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $133.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.89 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $127.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.97 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Vascular | ||||||
| 09/26/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Vascular | ||||||
| 09/26/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Vascular | ||||||
| 09/26/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Vascular | ||||||
| 09/26/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Vascular | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.61 | General |
| Category: Cardiovascular | ||||||
| 09/10/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Vascular | ||||||
| 08/26/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $133.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,635 | 1,752 | $271,033 | $89,022 |
| 2022 | 19 | 1,054 | 1,147 | $170,269 | $58,572 |
| 2021 | 18 | 1,057 | 1,155 | $167,396 | $58,710 |
| 2020 | 18 | 1,143 | 1,265 | $177,932 | $56,293 |
Total Patients
4,889
Total Services
5,319
Medicare Billing
$262,597
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 438 | 447 | $68,354 | $22,678 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 66 | 80 | $31,472 | $10,884 | 34.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 194 | 194 | $33,022 | $10,241 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 92 | $25,441 | $8,797 | 34.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 56 | $23,279 | $6,978 | 30.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 14 | $17,958 | $6,214 | 34.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 23 | 23 | $14,496 | $4,056 | 28.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 36 | $10,502 | $3,615 | 34.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 30 | $7,340 | $2,746 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $8,505 | $2,696 | 31.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 216 | 268 | $4,998 | $1,683 | 33.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 132 | 145 | $4,350 | $1,526 | 35.1% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 76 | 76 | $4,531 | $1,432 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,170 | $1,369 | 32.8% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 53 | 54 | $2,934 | $942.48 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $2,702 | $871.85 | 32.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 76 | 76 | $2,414 | $800.10 | 33.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 22 | 25 | $2,125 | $672.52 | 31.6% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 36 | 37 | $981.00 | $310.70 | 31.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 12 | 12 | $681.00 | $234.72 | 34.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 22 | 23 | $637.00 | $224.71 | 35.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 20 | 20 | $140.00 | $48.40 | 34.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 295 | 296 | $44,184 | $14,984 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 107 | $28,483 | $10,322 | 36.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 133 | 133 | $21,944 | $7,866 | 35.8% |
About Dr. David Beckner, MD
Dr. David Beckner, MD is a Cardiovascular Disease healthcare provider based in Bristol, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326074220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Beckner, MD has received a total of $8,902 in payments from pharmaceutical and medical device companies, with $1,887 received in 2024. These payments were reported across 493 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,902).
As a Medicare-enrolled provider, Beckner has provided services to 4,889 Medicare beneficiaries, totaling 5,319 services with total Medicare billing of $262,597. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical & Laboratory Immunology, Interventional Cardiology
- Location Bristol, TN
- Active Since 06/23/2006
- Last Updated 01/27/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1326074220
Products in Payments
- ENTRESTO (Drug) $1,185
- XIENCE SKYPOINT (Device) $875.12
- LifeVest (Device) $620.86
- BRILINTA (Drug) $558.95
- LEQVIO (Drug) $431.99
- ELIQUIS (Drug) $354.05
- Impella (Device) $308.43
- ZIO XT Patch (Device) $260.87
- Corlanor (Drug) $233.79
- XARELTO (Drug) $209.22
- CAMZYOS (Drug) $198.71
- JARDIANCE (Drug) $192.35
- Repatha (Biological) $188.11
- Zio monitor (Device) $133.76
- NEXLIZET (Drug) $124.99
- MULTAQ (Drug) $105.78
- Xience Alpine cornary stent system (Device) $105.69
- PRALUENT (Drug) $97.47
- CardioMEMS HF System (Device) $88.75
- Xience Sierra Coronary Stent System (Device) $83.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bristol
Dr. Pierre Istfan, Md, MD
Cardiovascular Disease — Payments: $93,680
Cardiovascular Disease $93,680
Dr. Jonathan Burress, Do, DO
Cardiovascular Disease — Payments: $46,129
Cardiovascular Disease $46,129
Dr. Mark Borsch, Md, MD
Cardiovascular Disease — Payments: $17,950
Cardiovascular Disease $17,950
Dr. Christopher Kennedy, Md, MD
Cardiovascular Disease — Payments: $4,645
Cardiovascular Disease $4,645
Atul Trivedi, Md, MD
Cardiovascular Disease — Payments: $2,083
Cardiovascular Disease $2,083
Dr. Joseph Marakovits, Md, MD
Cardiovascular Disease — Payments: $1,587
Cardiovascular Disease $1,587